{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:49:56Z","timestamp":1777560596110,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"publisher","award":["2P30CA068485-19"],"award-info":[{"award-number":["2P30CA068485-19"]}],"id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005923","name":"International Association for the Study of Lung Cancer","doi-asserted-by":"publisher","award":["P30-CA086485"],"award-info":[{"award-number":["P30-CA086485"]}],"id":[{"id":"10.13039\/100005923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005923","name":"International Association for the Study of Lung Cancer","doi-asserted-by":"publisher","award":["U01CA224276-01"],"award-info":[{"award-number":["U01CA224276-01"]}],"id":[{"id":"10.13039\/100005923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005923","name":"International Association for the Study of Lung Cancer","doi-asserted-by":"publisher","award":["U54CA217450-01"],"award-info":[{"award-number":["U54CA217450-01"]}],"id":[{"id":"10.13039\/100005923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005923","name":"International Association for the Study of Lung Cancer","doi-asserted-by":"publisher","award":["UG1CA233259"],"award-info":[{"award-number":["UG1CA233259"]}],"id":[{"id":"10.13039\/100005923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007208","name":"Vanderbilt-Ingram Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007208","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2K12CA090625-17"],"award-info":[{"award-number":["2K12CA090625-17"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jtocrr.2020.100024","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T04:26:14Z","timestamp":1583987174000},"page":"100024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease"],"prefix":"10.1016","volume":"1","author":[{"given":"Wade T.","family":"Iams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad R.","family":"Kopparapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anel","family":"Muterspaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Cann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"York","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leora","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Ancell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Wyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Hodsdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Ali","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee P.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Lovly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2020.100024_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","article-title":"Lung cancer statistics","volume":"893","author":"Torre","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-319-40389-2_14","article-title":"Small cell lung cancer","volume":"170","author":"Bernhardt","year":"2016","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jtocrr.2020.100024_bib3","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S1470-2045(18)30455-8","article-title":"Will liquid biopsies improve outcomes for patients with small-cell lung cancer?","volume":"19","author":"Blackhall","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.5335","article-title":"Association of chemoradiotherapy with outcomes among patients with stage I to II vs stage III small cell lung cancer: secondary analysis of a randomized clinical trial","volume":"5","author":"Salem","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nm.4239","article-title":"Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer","volume":"23","author":"Carter","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2020.100024_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor\u00a0cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtho.2019.10.007","article-title":"Profiling of circulating free\u00a0DNA using targeted and genome-wide sequencing in\u00a0patients with SCLC","volume":"15","author":"Mohan","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib9","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.7314\/APJCP.2014.15.19.8429","article-title":"Prognostic significance of circulating tumor cells in small-cell lung cancer patients: a meta-analysis","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jtocrr.2020.100024_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JTO.0b013e31823f125d","article-title":"Prognostic impact of circulating tumor cells in patients with small cell lung cancer","volume":"7","author":"Naito","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/fon.15.346","article-title":"Circulating tumor cell counts\/change for outcome prediction in patients with extensive-stage small-cell lung cancer","volume":"12","author":"Cheng","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib12","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/annonc\/mds138","article-title":"Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor","volume":"23","author":"Hiltermann","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.lungcan.2014.05.002","article-title":"Prognostic value of circulating tumor cells\u2019 reduction in patients with extensive small-cell lung cancer","volume":"85","author":"Normanno","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2020.100024_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ebiom.2016.06.032","article-title":"Identification of circulating tumor DNA for the early detection of small-cell lung cancer","volume":"10","author":"Fernandez-Cuesta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jtocrr.2020.100024_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.lungcan.2018.04.008","article-title":"Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance","volume":"120","author":"Du","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2020.100024_bib16","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/s41467-018-05327-w","article-title":"Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer","volume":"9","author":"Nong","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtocrr.2020.100024_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1196\/annals.1448.020","article-title":"Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer","volume":"1137","author":"Board","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtocrr.2020.100024_bib18","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1158\/1078-0432.CCR-19-0879","article-title":"Circulating tumor DNA profiling in small-cell lung cancer identifies potentially targetable alterations","volume":"25","author":"Devarakonda","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"suppl 15","key":"10.1016\/j.jtocrr.2020.100024_bib19","article-title":"Circulating cell-free tumor DNA (cfDNA) testing in small\u00a0cell lung cancer","volume":"34","author":"Morgensztern","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtho.2017.09.1951","article-title":"Longitudinal cell-free DNA analysis in patients with small cell lung\u00a0cancer reveals dynamic insights into treatment efficacy and disease relapse","volume":"13","author":"Almodovar","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib21","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtocrr.2020.100024_bib22","series-title":"R: A Language and Environment for Statistical Computing: Reference Index","year":"2010"},{"issue":"suppl","key":"10.1016\/j.jtocrr.2020.100024_bib23","article-title":"P2.06-028 A phase 2 study of prexasertib in patients with extensive stage small cell lung cancer: topic mesothelioma and SCLC","volume":"12","author":"Byers","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib24","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","article-title":"Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer","volume":"5","author":"Tie","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtocrr.2020.100024_bib25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/annonc\/mdz122","article-title":"Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial","volume":"30","author":"Tay","year":"2019","journal-title":"Ann Oncol"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364320300242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364320300242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:35:11Z","timestamp":1762986911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364320300242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2666364320300242"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2020.100024","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2020.100024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100024"}}